Causes	O
and	O
consequences	O
of	O
mesenteric	B:C0267407
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
intervention	O
-	O
a	O
nested	O
case	I:C0027775
control	I:C0027775
study	I:C0027775
Causes	O
and	O
consequences	O
of	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
procedures	O
have	O
not	O
been	O
studied	O
adequately	O
.	O

Causes	O
and	O
consequences	O
of	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	B:C1268307
-	I:C1268307
iliac	I:C1268307
intervention	O
-	O
a	O
nested	O
case	I:C0027775
control	I:C0027775
study	I:C0027775
Causes	O
and	O
consequences	O
of	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
procedures	O
have	O
not	O
been	O
studied	O
adequately	O
.	O

Causes	O
and	O
consequences	O
of	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
intervention	B:C0184661
-	O
a	O
nested	O
case	I:C0027775
control	I:C0027775
study	I:C0027775
Causes	O
and	O
consequences	O
of	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
procedures	O
have	O
not	O
been	O
studied	O
adequately	O
.	O

Causes	O
and	O
consequences	O
of	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
intervention	O
-	O
a	O
nested	B:C0027775
case	I:C0027775
control	I:C0027775
study	I:C0027775
Causes	O
and	O
consequences	O
of	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
procedures	O
have	O
not	O
been	O
studied	O
adequately	O
.	O

Causes	O
and	O
consequences	O
of	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
intervention	O
-	O
a	O
nested	O
case	I:C0027775
control	I:C0027775
study	I:C0027775
Causes	O
and	O
consequences	O
of	O
mesenteric	B:C0267407
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
procedures	O
have	O
not	O
been	O
studied	O
adequately	O
.	O

Causes	O
and	O
consequences	O
of	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
intervention	O
-	O
a	O
nested	O
case	I:C0027775
control	I:C0027775
study	I:C0027775
Causes	O
and	O
consequences	O
of	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	B:C1268307
-	I:C1268307
iliac	I:C1268307
procedures	O
have	O
not	O
been	O
studied	O
adequately	O
.	O

Causes	O
and	O
consequences	O
of	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
intervention	O
-	O
a	O
nested	O
case	I:C0027775
control	I:C0027775
study	I:C0027775
Causes	O
and	O
consequences	O
of	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
procedures	B:C0184661
have	O
not	O
been	O
studied	O
adequately	O
.	O

Causes	O
and	O
consequences	O
of	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
intervention	O
-	O
a	O
nested	O
case	I:C0027775
control	I:C0027775
study	I:C0027775
Causes	O
and	O
consequences	O
of	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
procedures	O
have	O
not	O
been	O
studied	B:C2603343
adequately	O
.	O

Consecutive	O
patients	O
with	O
mesenteric	B:C0267407
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
intervention	O
between	O
2011	O
and	O
2015	O
(	O
case	O
-	O
group	O
,	O
n	O
=	O
9	O
)	O
were	O
investigated	O
and	O
compared	O
with	O
age	O
,	O
gender	O
and	O
procedure	O
-	O
matched	O
random	O
controls	O
(	O
n	O
=	O
36	O
)	O
.	O

Consecutive	O
patients	O
with	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	B:C1268307
-	I:C1268307
iliac	I:C1268307
intervention	O
between	O
2011	O
and	O
2015	O
(	O
case	O
-	O
group	O
,	O
n	O
=	O
9	O
)	O
were	O
investigated	O
and	O
compared	O
with	O
age	O
,	O
gender	O
and	O
procedure	O
-	O
matched	O
random	O
controls	O
(	O
n	O
=	O
36	O
)	O
.	O

Consecutive	O
patients	O
with	O
mesenteric	O
embolization	I:C0267407
after	O
endovascular	O
aorto	O
-	I:C1268307
iliac	I:C1268307
intervention	B:C0184661
between	O
2011	O
and	O
2015	O
(	O
case	O
-	O
group	O
,	O
n	O
=	O
9	O
)	O
were	O
investigated	O
and	O
compared	O
with	O
age	O
,	O
gender	O
and	O
procedure	O
-	O
matched	O
random	O
controls	O
(	O
n	O
=	O
36	O
)	O
.	O

Compared	O
to	O
the	O
control	O
group	O
,	O
a	O
higher	O
proportion	O
of	O
patients	O
with	O
mesenteric	B:C0267407
embolization	I:C0267407
were	O
current	O
smokers	O
(	O
89	O
%	O
vs.	O
53	O
%	O
;	O
P	O
=	O
0.048	O
)	O
and	O
had	O
renal	O
insufficiency	I:C1565489
at	O
admission	O
(	O
44	O
%	O
vs.	O
11	O
%	O
;	O
P	O
=	O
0.019	O
)	O
.	O

Compared	O
to	O
the	O
control	O
group	O
,	O
a	O
higher	O
proportion	O
of	O
patients	O
with	O
mesenteric	O
embolization	I:C0267407
were	O
current	O
smokers	B:C0337664
(	O
89	O
%	O
vs.	O
53	O
%	O
;	O
P	O
=	O
0.048	O
)	O
and	O
had	O
renal	O
insufficiency	I:C1565489
at	O
admission	O
(	O
44	O
%	O
vs.	O
11	O
%	O
;	O
P	O
=	O
0.019	O
)	O
.	O

Compared	O
to	O
the	O
control	O
group	O
,	O
a	O
higher	O
proportion	O
of	O
patients	O
with	O
mesenteric	O
embolization	I:C0267407
were	O
current	O
smokers	O
(	O
89	O
%	O
vs.	O
53	O
%	O
;	O
P	O
=	O
0.048	O
)	O
and	O
had	O
renal	B:C1565489
insufficiency	I:C1565489
at	O
admission	O
(	O
44	O
%	O
vs.	O
11	O
%	O
;	O
P	O
=	O
0.019	O
)	O
.	O

Compared	O
to	O
the	O
control	O
group	O
,	O
a	O
higher	O
proportion	O
of	O
patients	O
with	O
mesenteric	O
embolization	I:C0267407
were	O
current	O
smokers	O
(	O
89	O
%	O
vs.	O
53	O
%	O
;	O
P	O
=	O
0.048	O
)	O
and	O
had	O
renal	O
insufficiency	I:C1565489
at	O
admission	B:C0809949
(	O
44	O
%	O
vs.	O
11	O
%	O
;	O
P	O
=	O
0.019	O
)	O
.	O

In	O
patients	O
treated	O
for	O
aorto	B:C1268307
-	I:C1268307
iliac	I:C1268307
occlusive	O
disease	I:C0003838
,	O
aortic	O
irregularity	O
(	O
shagginess	O
)	O
was	O
more	O
severe	O
(	O
P	O
=	O
0.015	O
)	O
,	O
visceral	O
thrombus	O
volume	O
was	O
larger	O
(	O
P	O
=	O
0.004	O
)	O
and	O
operation	O
-	O
time	O
was	O
longer	O
(	O
P	O
=	O
0.009	O
)	O
among	O
the	O
case	O
-	O
group	O
.	O

In	O
patients	O
treated	O
for	O
aorto	O
-	I:C1268307
iliac	I:C1268307
occlusive	B:C0003838
disease	I:C0003838
,	O
aortic	O
irregularity	O
(	O
shagginess	O
)	O
was	O
more	O
severe	O
(	O
P	O
=	O
0.015	O
)	O
,	O
visceral	O
thrombus	O
volume	O
was	O
larger	O
(	O
P	O
=	O
0.004	O
)	O
and	O
operation	O
-	O
time	O
was	O
longer	O
(	O
P	O
=	O
0.009	O
)	O
among	O
the	O
case	O
-	O
group	O
.	O

In	O
patients	O
treated	O
for	O
aorto	O
-	I:C1268307
iliac	I:C1268307
occlusive	O
disease	I:C0003838
,	O
aortic	B:C0003483
irregularity	O
(	O
shagginess	O
)	O
was	O
more	O
severe	O
(	O
P	O
=	O
0.015	O
)	O
,	O
visceral	O
thrombus	O
volume	O
was	O
larger	O
(	O
P	O
=	O
0.004	O
)	O
and	O
operation	O
-	O
time	O
was	O
longer	O
(	O
P	O
=	O
0.009	O
)	O
among	O
the	O
case	O
-	O
group	O
.	O

In	O
patients	O
treated	O
for	O
aorto	O
-	I:C1268307
iliac	I:C1268307
occlusive	O
disease	I:C0003838
,	O
aortic	O
irregularity	O
(	O
shagginess	O
)	O
was	O
more	O
severe	O
(	O
P	O
=	O
0.015	O
)	O
,	O
visceral	B:C0442045
thrombus	O
volume	O
was	O
larger	O
(	O
P	O
=	O
0.004	O
)	O
and	O
operation	O
-	O
time	O
was	O
longer	O
(	O
P	O
=	O
0.009	O
)	O
among	O
the	O
case	O
-	O
group	O
.	O

In	O
patients	O
treated	O
for	O
aorto	O
-	I:C1268307
iliac	I:C1268307
occlusive	O
disease	I:C0003838
,	O
aortic	O
irregularity	O
(	O
shagginess	O
)	O
was	O
more	O
severe	O
(	O
P	O
=	O
0.015	O
)	O
,	O
visceral	O
thrombus	B:C0087086
volume	O
was	O
larger	O
(	O
P	O
=	O
0.004	O
)	O
and	O
operation	O
-	O
time	O
was	O
longer	O
(	O
P	O
=	O
0.009	O
)	O
among	O
the	O
case	O
-	O
group	O
.	O

In	O
patients	O
treated	O
for	O
aorto	O
-	I:C1268307
iliac	I:C1268307
occlusive	O
disease	I:C0003838
,	O
aortic	O
irregularity	O
(	O
shagginess	O
)	O
was	O
more	O
severe	O
(	O
P	O
=	O
0.015	O
)	O
,	O
visceral	O
thrombus	O
volume	O
was	O
larger	O
(	O
P	O
=	O
0.004	O
)	O
and	O
operation	B:C0543467
-	O
time	O
was	O
longer	O
(	O
P	O
=	O
0.009	O
)	O
among	O
the	O
case	O
-	O
group	O
.	O

However	O
,	O
no	O
difference	O
s	O
were	O
found	O
between	O
cases	O
with	O
mesenteric	B:C0267407
embolization	I:C0267407
caused	O
by	O
endovascular	O
aortic	I:C0918249
aneurysm	I:C0918249
repair	I:C0918249
versus	O
controls	O
.	O

However	O
,	O
no	O
difference	O
s	O
were	O
found	O
between	O
cases	O
with	O
mesenteric	O
embolization	I:C0267407
caused	O
by	O
endovascular	B:C0918249
aortic	I:C0918249
aneurysm	I:C0918249
repair	I:C0918249
versus	O
controls	O
.	O

Myoglobin	B:C0027078
,	O
arterial	O
blood	O
lactate	O
,	O
aspartate	O
aminotransferase	I:C0004002
,	O
alanine	O
aminotransferase	I:C0001899
and	O
pancreatic	O
amylase	I:C0301812
levels	O
were	O
elevated	O
in	O
100	O
%	O
,	O
67	O
%	O
,	O
89	O
%	O
,	O
89	O
%	O
,	O
89	O
%	O
and	O
56	O
%	O
of	O
patients	O
with	O
mesenteric	O
embolization	I:C0267407
,	O
respectively	O
.	O

Myoglobin	O
,	O
arterial	O
blood	O
lactate	O
,	O
aspartate	B:C0004002
aminotransferase	I:C0004002
,	O
alanine	O
aminotransferase	I:C0001899
and	O
pancreatic	O
amylase	I:C0301812
levels	O
were	O
elevated	O
in	O
100	O
%	O
,	O
67	O
%	O
,	O
89	O
%	O
,	O
89	O
%	O
,	O
89	O
%	O
and	O
56	O
%	O
of	O
patients	O
with	O
mesenteric	O
embolization	I:C0267407
,	O
respectively	O
.	O

Myoglobin	O
,	O
arterial	O
blood	O
lactate	O
,	O
aspartate	O
aminotransferase	I:C0004002
,	O
alanine	B:C0001899
aminotransferase	I:C0001899
and	O
pancreatic	O
amylase	I:C0301812
levels	O
were	O
elevated	O
in	O
100	O
%	O
,	O
67	O
%	O
,	O
89	O
%	O
,	O
89	O
%	O
,	O
89	O
%	O
and	O
56	O
%	O
of	O
patients	O
with	O
mesenteric	O
embolization	I:C0267407
,	O
respectively	O
.	O

Myoglobin	O
,	O
arterial	O
blood	O
lactate	O
,	O
aspartate	O
aminotransferase	I:C0004002
,	O
alanine	O
aminotransferase	I:C0001899
and	O
pancreatic	B:C0301812
amylase	I:C0301812
levels	O
were	O
elevated	O
in	O
100	O
%	O
,	O
67	O
%	O
,	O
89	O
%	O
,	O
89	O
%	O
,	O
89	O
%	O
and	O
56	O
%	O
of	O
patients	O
with	O
mesenteric	O
embolization	I:C0267407
,	O
respectively	O
.	O

Myoglobin	O
,	O
arterial	O
blood	O
lactate	O
,	O
aspartate	O
aminotransferase	I:C0004002
,	O
alanine	O
aminotransferase	I:C0001899
and	O
pancreatic	O
amylase	I:C0301812
levels	O
were	O
elevated	O
in	O
100	O
%	O
,	O
67	O
%	O
,	O
89	O
%	O
,	O
89	O
%	O
,	O
89	O
%	O
and	O
56	O
%	O
of	O
patients	O
with	O
mesenteric	B:C0267407
embolization	I:C0267407
,	O
respectively	O
.	O

The	O
in	O
-	O
hospital	O
mortality	O
was	O
17	O
%	O
(	O
1/6	O
)	O
in	O
patients	O
treated	O
with	O
open	B:C0175566
abdomen	O
therapy	O
,	O
of	O
whom	O
five	O
were	O
managed	O
with	O
stomas	O
.	O

The	O
in	O
-	O
hospital	O
mortality	O
was	O
17	O
%	O
(	O
1/6	O
)	O
in	O
patients	O
treated	O
with	O
open	O
abdomen	B:C0000726
therapy	O
,	O
of	O
whom	O
five	O
were	O
managed	O
with	O
stomas	O
.	O

The	O
in	O
-	O
hospital	O
mortality	O
was	O
17	O
%	O
(	O
1/6	O
)	O
in	O
patients	O
treated	O
with	O
open	O
abdomen	O
therapy	O
,	O
of	O
whom	O
five	O
were	O
managed	O
with	O
stomas	B:C1955856
.	O

Smoking	O
cessation	O
,	O
careful	O
patient	B:C0242802
selection	I:C0242802
and	O
procedure	O
planning	O
with	O
identification	O
of	O
severe	O
shaggy	O
aortas	O
might	O
prevent	O
mesenteric	O
embolization	I:C0267407
during	O
aorto	O
-	I:C1268307
iliac	I:C1268307
procedures	O
.	O

Smoking	O
cessation	O
,	O
careful	O
patient	O
selection	I:C0242802
and	O
procedure	O
planning	O
with	O
identification	O
of	O
severe	O
shaggy	O
aortas	B:C0003483
might	O
prevent	O
mesenteric	O
embolization	I:C0267407
during	O
aorto	O
-	I:C1268307
iliac	I:C1268307
procedures	O
.	O

Smoking	O
cessation	O
,	O
careful	O
patient	O
selection	I:C0242802
and	O
procedure	O
planning	O
with	O
identification	O
of	O
severe	O
shaggy	O
aortas	O
might	O
prevent	O
mesenteric	B:C0267407
embolization	I:C0267407
during	O
aorto	O
-	I:C1268307
iliac	I:C1268307
procedures	O
.	O

Smoking	O
cessation	O
,	O
careful	O
patient	O
selection	I:C0242802
and	O
procedure	O
planning	O
with	O
identification	O
of	O
severe	O
shaggy	O
aortas	O
might	O
prevent	O
mesenteric	O
embolization	I:C0267407
during	O
aorto	B:C1268307
-	I:C1268307
iliac	I:C1268307
procedures	O
.	O

Smoking	O
cessation	O
,	O
careful	O
patient	O
selection	I:C0242802
and	O
procedure	O
planning	O
with	O
identification	O
of	O
severe	O
shaggy	O
aortas	O
might	O
prevent	O
mesenteric	O
embolization	I:C0267407
during	O
aorto	O
-	I:C1268307
iliac	I:C1268307
procedures	B:C0184661
.	O

In	O
suspected	O
cases	O
of	O
mesenteric	B:C0267407
embolization	I:C0267407
,	O
elevated	O
myoglobin	O
and	O
arterial	O
blood	O
lactate	O
may	O
be	O
indicative	O
of	O
this	O
complication	O
.	O

In	O
suspected	O
cases	O
of	O
mesenteric	O
embolization	I:C0267407
,	O
elevated	O
myoglobin	B:C0027078
and	O
arterial	O
blood	O
lactate	O
may	O
be	O
indicative	O
of	O
this	O
complication	O
.	O

In	O
suspected	O
cases	O
of	O
mesenteric	O
embolization	I:C0267407
,	O
elevated	O
myoglobin	O
and	O
arterial	O
blood	O
lactate	O
may	O
be	O
indicative	O
of	O
this	O
complication	B:C0009566
.	O

Aspartate	B:C0004002
and	O
alanine	O
aminotranferases	I:C0001899
,	O
as	O
well	O
as	O
pancreatic	O
amylase	I:C0301812
,	O
are	O
also	O
relevant	O
tests	O
to	O
assess	O
the	O
extent	O
of	O
organ	O
ischaemia	O
.	O

Aspartate	O
and	O
alanine	B:C0001899
aminotranferases	I:C0001899
,	O
as	O
well	O
as	O
pancreatic	O
amylase	I:C0301812
,	O
are	O
also	O
relevant	O
tests	O
to	O
assess	O
the	O
extent	O
of	O
organ	O
ischaemia	O
.	O

Aspartate	O
and	O
alanine	O
aminotranferases	I:C0001899
,	O
as	O
well	O
as	O
pancreatic	B:C0301812
amylase	I:C0301812
,	O
are	O
also	O
relevant	O
tests	O
to	O
assess	O
the	O
extent	O
of	O
organ	O
ischaemia	O
.	O

Aspartate	O
and	O
alanine	O
aminotranferases	I:C0001899
,	O
as	O
well	O
as	O
pancreatic	O
amylase	I:C0301812
,	O
are	O
also	O
relevant	O
tests	O
to	O
assess	O
the	O
extent	B:C0439792
of	O
organ	O
ischaemia	O
.	O

Aspartate	O
and	O
alanine	O
aminotranferases	I:C0001899
,	O
as	O
well	O
as	O
pancreatic	O
amylase	I:C0301812
,	O
are	O
also	O
relevant	O
tests	O
to	O
assess	O
the	O
extent	O
of	O
organ	B:C0178784
ischaemia	O
.	O

Aspartate	O
and	O
alanine	O
aminotranferases	I:C0001899
,	O
as	O
well	O
as	O
pancreatic	O
amylase	I:C0301812
,	O
are	O
also	O
relevant	O
tests	O
to	O
assess	O
the	O
extent	O
of	O
organ	O
ischaemia	B:C0022116
.	O

Damage	O
control	O
with	O
open	B:C0175566
abdomen	O
therapy	O
and	O
the	O
creation	O
of	O
stomas	O
seem	O
justifiable	O
in	O
order	O
to	O
improve	O
survival	O
in	O
this	O
complex	O
situation	O
.	O

Damage	O
control	O
with	O
open	O
abdomen	B:C0000726
therapy	O
and	O
the	O
creation	O
of	O
stomas	O
seem	O
justifiable	O
in	O
order	O
to	O
improve	O
survival	O
in	O
this	O
complex	O
situation	O
.	O

Damage	O
control	O
with	O
open	O
abdomen	O
therapy	O
and	O
the	O
creation	B:C0441513
of	O
stomas	O
seem	O
justifiable	O
in	O
order	O
to	O
improve	O
survival	O
in	O
this	O
complex	O
situation	O
.	O

Damage	O
control	O
with	O
open	O
abdomen	O
therapy	O
and	O
the	O
creation	O
of	O
stomas	B:C1955856
seem	O
justifiable	O
in	O
order	O
to	O
improve	O
survival	O
in	O
this	O
complex	O
situation	O
.	O

Damage	O
control	O
with	O
open	O
abdomen	O
therapy	O
and	O
the	O
creation	O
of	O
stomas	O
seem	O
justifiable	O
in	O
order	O
to	O
improve	B:C0184511
survival	O
in	O
this	O
complex	O
situation	O
.	O

